AI in Pharma & Healthcare: Hype or Reality?
Artificial Intelligence was long hailed as the revolutionary force that would transform the pharmaceutical and healthcare industries. But now that the initial excitement has settled, what’s left of the big promises? Which AI applications have actually made a difference, where are the biggest hurdles, and what comes next?
Find the answers in our latest whitepaper: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
This whitepaper, created with STORM by Stanford University and edited by Dr Henriette Wolf-Klein, offers a clear and concise overview of real-world AI applications – from accelerating drug discovery and optimizing clinical trials to improving diagnostics and enabling personalized medicine.
Discover which technologies have proven themselves in practice, where the industry still faces challenges, and how ethical and regulatory questions are shaping AI adoption today. Real-life case studies and emerging trends help you separate lasting innovation from fleeting hype.
Download your copy now: “Current Implementation of AI Applications in the Pharmaceutical and Healthcare Industry.”
We hope you find the content insightful and engaging.
With this qualification course, you can continue your education in a structured manner in all CMC topics, with a technical focus on development methods, manufacturing processes, CMC documents, change management, and much more.
Attend one of our free pre-meetings to familiarise yourself with the Learning Space and the various ways in which you can interact during the event
Participants in this qualification course will receive thorough training on the main regulatory duties, from marketing authorisation applications to lifecycle management. This is the ideal preparation for starting a career in drug regulatory affairs. After course completion a certificate will be awarded.
Global regulatory requirements for drug device combination products (DDCs): You will receive a regulatory overview for the EU, the US, China, MENA, Mexico and other LATAM countries, plus you will obtain tips and tricks by (local) experts on how to speed up the approval process.
This seminar provides an in-depth exploration of the marketing authorisation dossier and the electronic submission process, focusing on the CTD structure and Modules 1-5. Participants will gain practical knowledge and strategies for successful drug approval applications in the EU.
Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.
Enhance your skills in writing key pharmacovigilance safety documents. In this two-day online seminar, you will gain a comprehensive understanding of the regulatory requirements and hands-on experience in crafting and maintaining PSUR, RMP, and DSUR. Learn best practices, avoid common pitfalls, and address global challenges to become a proficient "Pharmacovigilance Writer"!
This online training will give you in-depth knowledge on the CMC requirements for marketing authorisation. Take the chance to participate in our virtual seminar and get qualified.
The compact course with a content focus on the development, production and analytics of biotech drugs. Secure your place and qualify now! All three course days can be booked individually (single day = 1.290€ plus VAT) - for booking, please contact us!
This course familiarises you with regulatory post-approval duties and provides first-hand information on variation submission, PV activities and labelling changes.
This online course offers an in-depth overview of the medical device approval process in key global markets: Regulatory strategies, approval steps and timelines for global market access, with a focus on North and South America, the Asia-Pacific region and China.
